**Core Concept**
Gestational trophoblastic neoplasia (GTN) is a heterogeneous group of tumors arising from the placental tissue, and the risk stratification is crucial for determining the appropriate treatment and follow-up. The risk classification of GTN is primarily based on the World Health Organization (WHO) scoring system, which considers various factors, including the persistence of hCG levels, the presence of metastasis, and the interval between the antecedent pregnancy and the diagnosis.

**Why the Correct Answer is Right**
The high-risk group in GTN is typically defined as patients who develop the disease after a molar pregnancy or abortion, as these cases are associated with a higher risk of metastasis and resistance to chemotherapy. This is because molar pregnancies and abortions are often associated with a higher risk of genetic abnormalities, such as aneuploidy and mutations in the TP53 gene, which can contribute to the development of aggressive GTN.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because the development of GTN after a term pregnancy or a normal delivery is not necessarily a high-risk factor.
**Option B:** Incorrect because the presence of metastasis is a high-risk factor, but it is not the only criterion for classifying GTN as high-risk.
**Option C:** Incorrect because the persistence of hCG levels is a high-risk factor, but it is not the only criterion for classifying GTN as high-risk.

**Clinical Pearl / High-Yield Fact**
It is essential to remember that GTN can occur after any pregnancy, including term pregnancies, and that the risk of developing GTN is higher in patients with a history of molar pregnancies or abortions.

**Correct Answer:** D.